Improved surgical margins with neoadjuvant versus adjuvant chemotherapy in clinical stage I resectable pancreatic adenocarcinoma: A National Cancer Database study.

Geoffrey Bellini,Samit K. Datta,Nicholas Sich,Maharaj Singh,James L. Weese,Federico Augusto Sanchez,Nalini M. Guda,Wesley Allan Papenfuss,Aaron Chevinsky

Improved surgical margins with neoadjuvant versus adjuvant chemotherapy in clinical stage I resectable pancreatic adenocarcinoma: A National Cancer Database study.

2020

Geoffrey Bellini
Samit K. Datta
Nicholas Sich
Maharaj Singh
James L. Weese
Federico Augusto Sanchez
Nalini M. Guda
Wesley Allan Papenfuss
Aaron Chevinsky

651Background: A strengthening consensus exists for neoadjuvant therapy (NAT) in borderline resectable pancreatic adenocarcinoma (PA), but the utilization of NAT in resectable stage I PA remains co...

Keywords:

Cancer
Adenocarcinoma
Internal medicine
Adjuvant
Medicine
Chemotherapy
Oncology
Pathology
database study
borderline resectable
Neoadjuvant therapy
adjuvant chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations